Adverse outcomes | Overall | Patient age | |||
Young (≤18 years) | Adult (19–59 years) | Elderly (≥60 years) | P value | ||
(n=29 231) | (n=948) | (n=9195) | (n=19 088) | ||
In-hospital death, n (%) | 20 370 (70) | 521 (55) | 6037 (66) | 13 812 (72) | <0.001 |
Died within 30-day, n (%) | 17 910 (61) | 339 (36) | 5410 (59) | 12 161 (64) | <0.001 |
Severe lower extremity ischemia, n (%) | 98 (0.3) | 13 (1.4) | 42 (0.5) | 43 (0.2) | <0.001 |
Fasciotomy | 42 (0.1) | 6 (0.6) | 20 (0.2) | 16 (0.1) | <0.001 |
Amputation at any level | 60 (0.2) | 7 (0.7) | 25 (0.3) | 28 (0.1) | <0.001 |
VA-ECMO duration (days), mean (±SD) | 2.9 (8.6) | 8.6 (19) | 3.3 (12) | 2.4 (5.2) | <0.001 |
Length of hospital stay, (days), mean (±SD) | 28 (54) | 72 (125) | 29 (61) | 25 (42) | <0.001 |
VA-ECMO, venoarterial extracorporeal membrane oxygenation.